Company Pherecydes Pharma Euronext Paris

Pherecydes Pharma is specialized in the research and development of anti-infective therapies based on bacteriophages. Phagotherapy is an innovative approach to treat bacterial infections, including antibiotic-resistant infections, using phages, natural predators of bacteria that have no effect on eukaryotic cells, including human cells.

Number of employees: 29